1mg semaglutide weight loss 2.4 mg weekly vs 1 mg and placebo in #obesity with T2 #diabetes Better loss, better reduction in waist circumference and slightly better HbA1c lowering (sugars) with fewer other sugar-lowering Semaglutide (Ozempic/Wegovy) shows 3-year efficacy

CAS number: 2381089-83-2

Drink plenty of water to help with constipation

How Retatrutide Works A Quick Refresher Retatrutide is a triple-receptor agonist, meaning it activates three distinct hormone receptors simultaneously: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

In 2025, Divis signed a long-term manufacturing and supply agreement with a global pharma major for advanced intermediateswidely read by the sell side as tied to the GLP1 wave and very likely involving Lilly or similar marquee clients

Funding Supported by the University of Zagreb, Zagreb, Croatia (Grant BM 099)